Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 400,000 Shares

Oct 02, 2010

CEO of Cell Therapeutics Inc. (CTIC, Financial) James A Bianco sells 400,000 shares of CTIC on 09/30/2010 at an average price of $0.38 a share.

Cell Therapeutics Inc. has a market cap of $289.8 million; its shares were traded at around $0.382 with and P/S ratio of 3621.8.

CTIC is in the portfolios of Steven Cohen of SAC Capital Advisors.

CEO Recent Trades:

Sell: CEO James A Bianco sold 250,000 shares of CTIC stock on 08/10/2010 at the average price of 0.4. James A Bianco owns at least 13,422,660 shares after this. The price of the stock has decreased by 4.5% since.
Sell: CEO James A Bianco sold 500,000 shares of CTIC stock on 06/30/2010 at the average price of 0.37. James A Bianco owns at least 3,706,050 shares after this. The price of the stock has increased by 3.24% since.

Directors and Officers Recent Trades:

Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 09/30/2010 at the average price of 0.38. Phillip M Phd Nudelman owns at least 2,434,865 shares after this. The price of the stock has increased by 0.53% since.
Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 08/31/2010 at the average price of 0.36. Phillip M Phd Nudelman owns at least 2,454,865 shares after this. The price of the stock has increased by 6.11% since.
Sell: Director Richard L Love sold 75,000 shares of CTIC stock on 08/23/2010 at the average price of 0.37. Richard L Love owns at least 2,357,773 shares after this. The price of the stock has increased by 3.24% since.
Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 07/30/2010 at the average price of 0.4. Phillip M Phd Nudelman owns at least 2,494,865 shares after this. The price of the stock has decreased by 4.5% since.
Sell: Director Phillip M Phd Nudelman sold 40,000 shares of CTIC stock on 06/30/2010 at the average price of 0.39. Phillip M Phd Nudelman owns at least 1,036,306 shares after this. The price of the stock has decreased by 2.05% since.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.